Answers are grounded in this paper and cite their sources.
JI is a relatively common disease phenotype in children with CD that requires aggressive nutritional and surgical intervention. Future studies are required to determine if the early detection and use of immune modulators may lessen the morbidity associated with proximal small bowel disease.
No takes yet. Share an insight, caveat, or question.
Attard et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: